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Summary  
Adult liver cells have been considered restricted regarding their fate and lineage potential.  
That is, hepatocytes have been thought able only to generate hepatocytes and duct cells only 
duct cells. While this may be the case for the majority of scenarios in states of quiescence or 
homeostasis, evidence suggests that liver cells are capable of interconverting between cellular 
states of distinct phenotypic traits. This interconversion or plasticity, had been suggested by 
classical studies using cellular markers but recently, lineage tracing approaches have proven 
that cells are highly plastic and retain an extraordinary ability to respond differently to normal 
tissue homeostasis, tissue repair or when challenged to expand ex vivo or to differentiate upon 
transplantation. Stemness, as “self-renewal and multipotency”, seems not to be limited to a 
particular cell type but rather to a cellular state in which cells exhibit a high degree of 
plasticity and can move back and forth in different phenotypic states. For instance, upon 
damage cells can de-differentiate to acquire stem cell potential that allows them to self-renew, 
repopulate a damaged tissue and then be able to undergo differentiation. In this review, we 
will discuss the evidence on cellular plasticity in the liver focusing our attention on two 
markers, EpCAM and Lgr5, which identify cells with stem cell potential.   
 
Stem Cell Fate and Stem Cell Potential: different sides of cellular plasticity  
The stem cell state is defined by the ability of the cells to fulfill the two following 
criteria: “self-renewal” and “multi-potency” (1). Several approaches have been used to 
identify cells that exhibit stem cell characteristics. In vivo, long-term label-retaining and 
genetic lineage tracing have been commonly used to identify both quiescent and actively 
cycling stem cells in several tissues (1). Alternatively, in vitro clonogenicity and multilineage 
differentiation as well as long-term repopulation following transplantation have also been 
regarded extensively as assays to demonstrate stem cell potential (1).  
Of note, stem cell fate and stem cell potential might have not always been adequately used. 
Stem cell fate indicates a cell that already fulfills the stem cell criteria, while stem cell 
potential represents a cell with the competence to acquire a stem cell state, depending on the 
environment or condition. Confusion might have been caused by the extensive plasticity of 
animal cells. Cellular plasticity is understood as the propensity of a cell to, under certain 
circumstances, acquire biological properties of other cells (2). Because stem cell potential can 
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be defined as the ability of cells (differentiated cells or progenitors) to acquire a stem cell 
state, stem cell potential would therefore be a specific manifestation of plasticity (2). On the 
other hand, though, one could also consider that this return to a more primitive state is a form 
of in vivo reprogramming. However, “reprograming” is associated with a complete reversion 
to a pluripotent state, as seen in to John Gurdon’s tadpole experiments (3). In this review we 
opt to use “plasticity” as the ability of cells to acquire other cellular fates, distinct from 
reprograming, and thus acquisition of a tissue-restricted stem cell fate or potential would be 
one form of plasticity.  
In the liver, several authors had suggested the existence of plasticity in adult liver cells (see 
ref (4-7) for details), but now, the advance on mouse genetic engineering, imaging tools and 
the possibility of culturing cells in vitro have provided further evidence for cellular plasticity 
in the liver and other organs. Here, we aim to review the different evidences of liver cellular 
plasticity. We will use EpCAM and Lgr5 as examples of markers that identify cells with 
cellular plasticity and stem cell potential in the liver.  
 
Cellular plasticity: an old player in the new viewpoint of looking at liver repair 
Increasing evidence in stem cell behaviour in the intestine, hair follicle or bone 
marrow, suggests that cells often exist in two distinct states: an active stem cell state and a 
potential state that appears upon stem cell ablation. Studies on both, intestinal and hair follicle 
show that when the stem cell pool is ablated, those cells which retain stem cell potential 
(usually early descendants of the stem cell) acquire properties of a stem cell 
(potential/plasticity) to be able to repair the tissue and reinstate homeostasis [nicely reviewed 
by Cedric Blanpain (2)]. Similarly to the intestine or skin, organs with slow physiological 
turnover, such as the lung, have also shown to possess a high degree of cellular plasticity. For 
instance, after the ablation of airway stem cells, lineage tracing demonstrated that the luminal 
secretory cells had dedifferentiated into multipotent basal stem cells (8). This capacity of cells 
to acquire a stem cell state may have a more general role in the regeneration of many tissues, 
including the liver. 
The primary functional unit of the liver is the hepatic lobule or acinus, structure 
resulting from the interaction between epithelial (hepatocytes and ductal cells), endothelial 
(sinusoidal cells), and mesenchymal cells (portal fibroblasts and stellate cells) (9).  
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In the liver, during embryonic development, hepatoblasts behave as stem cells, as they 
are capable of self-duplicating while giving rise to hepatocytes and ductal cells (elegantly 
reviewed by (9)). During adulthood, the cellular turnover is rather slow, with a period of more 
than several months (10). Extensive lineage tracing approaches in the mouse model indicate 
that, if adult liver stem cells exist, their contribution to the normal homeostasis is negligible, 
at least in the mouse model, with the exception for one report, that utilizing genetic lineage 
tracing based on Sox9CeER, demonstrated that adult hepatocytes can also derive from 
specialized ductal progenitors (11). However, other studies did not find evidence for such 
liver progenitors (12, 13). Also, recently, a subset of centrolobular hepatocytes has been 
shown to contribute to the normal homeostasis of the hepatocyte compartment (14, 15). On 
the other hand, using clonogenic assays, it has been reported that EpCAM-positive (or 
EpCAM+) human liver cells, isolated from healthy fetal, neonatal, pediatric and adult (16, 17) 
donors display characteristics of liver stem/progenitors both in vitro and in vivo, after 
transplantation. The later could be understood as the ability of some resident cells to harbor 
stem cell potential during homeostasis. However, it is worth taking into account that 
clonogenic assay implies isolating the cells from their environment, which could trigger the 
activation of a stem cell state as a result of a damage to the tissue, as it happens during 
regenerative response. Therefore, as we will discuss below, the result from clonogenic assays 
could also be interpreted as a response of the cells to the external cue of being isolated from 
their tissue, which does not necessarily reflect what happens during in vivo homeostasis. 
The liver excels by its extensive damage-repair response (see Figure 1A) (18). The cells 
responsible for the facultative regenerative response of the liver are subject to extensive 
investigations. This has led to 2 schools of thought: the followers and the opponents of the 
existence/activation of a progenitor response that would contribute to the repair of the tissue 
after damage. On the one hand, mouse lineage-tracing approaches in combination with 
specific cell markers have allowed the identification of cells that upon damage will 
differentiate into hepatocytes and/or ductal cells (11, 19-22). However, in all of these studies, 
the lack of in vivo clonal analysis hampers the conclusion whether these cells are truly bi-
potential. Thus, until this is not fully addressed, the existence of true bi-potential cells induced 
after damage remains unanswered. Also, in vitro studies from several groups indicate that 
isolated progenitors from mouse injured livers display bi-potentiality in vitro and in vivo 
following transplantation into FAH mutant mouse (19, 20, 22, 23). Also, recently, Kaneko et 
al. showed that upon damage, biliary cells expand towards the injured area, suggesting that 
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the expanded biliary branches could contribute as a source or as a niche during the 
regeneration response (24). On the other hand, reports using viral-mediated Cre lineage 
tracing approaches have recently ruled out the existence of a progenitor-driven regeneration in 
the mouse (25, 26). One explanation for this paradox could be that liver pathologies in these 
models are not sufficiently severe so remaining “healthy” hepatocytes can still extensively 
proliferate and repair the lost tissue. Notably, in zebrafish, genetic ablation of the hepatocyte 
compartment followed by lineage tracing resulted in ductal cells de-differentiating and 
acquiring a stem cell fate, where biliary tree stem/progenitors repair the damaged liver (27). 
Also, upon complete senescence of the hepatocyte compartment, Forbes and colleagues have 
recently observed a similar widespread ductular reaction in the mouse (28). Moreover, recent 
studies indicate that following transplantation and injury mouse hepatocytes can acquire a 
ductal phenotype and stem cell state and can differentiate towards hepatocytes and ductal cells 
upon demand (29). Similarly, in human liver failure, ductal cells are detected close to clusters 
of hepatocytes that also express ductal markers (30). Whether in humans, the ductal cells 
derive from hepatocytes or inversely might be difficult to determine without the possibility of 
tracking the cells in vivo.  
 
Overall, these studies suggest that the adult liver cellular state (either hepatocyte or duct) is 
not fixed but can be modulated at request. Differentiated states can be de-differentiated or 
pushed to a more “stem cell state” upon demand. In these reports, adult liver cells fulfill the 
stem cell criteria, whereby they will proliferate and differentiate depending on the type and 
extent of the damage and the model organism studied. The differences that are being observed 
might be due to the type of injury, type of model (human, mouse, rat, zebrafish) or even type 
of technique utilized to validate stem cell fate (lineage labeling) or stem cell potential 
(transplantation, clonogenicity, lineage tracing). Taking into account that cellular plasticity 
will enable cells that, a priori do not exhibit stem cell properties, to acquire stem cell potential 
if needed (self-renew and differentiate), we therefore here propose a more reconciling 
concept, whereby liver cells possess an extreme plasticity that allow the acquisition of 
different states (differentiation-stemness) depending on the environment and tissue demand 
(Figure 1A).  
 
Isolation of liver cells with clonogenic and multilineage potential  
As mentioned, different experimental approaches have been used to identify stem cells 
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or cells with stem cell potential: from lineage tracing to transplantation or colony formation 
(see Figure 1). 
Using antibodies and/or flow cytometry-based cell separation methods, several groups have 
actually managed to isolate cell populations from the adult liver (31). Here we will focus on 
the use of cellular markers that identify liver cells with clonogenic and multilineage potential 
(9, 32). EpCAM (16), Lgr5 (22), CD133 (33), MIC1-1C3 (33), Foxl1 (19), OPN (12), Sox9 
(20), and CD24 (34) antibodies or a combination of them, have been mostly used to enrich for 
cells that, upon culture and/or transplantation, exhibit clonogenic and multilineage 
competency. Also, activities (functionality of the cell) that are enhanced in stem/progenitor 
cells can be used to isolate putative cells with stem cell potential, for instance aldehyde 
dehydrogenase activity (35) (Figure 1B). Unfortunately, the aforementioned markers are 
usually expressed on regular biliary epithelial cells, which complicate their isolation. 
Similarly, expression of markers has been shown in a subpopulation of rat progenitors, but is 
not found in the mouse counterpart. Conversely, OPN and MIC1-1C3 are regarded as 
equivalent progenitor markers at least in mice. Also, some markers are only appearing upon 
liver injury (like Lgr5 or Foxl1), while are not present under homeostasis conditions. Together 
with the fact that stem/progenitor cell populations represent a spectrum of differentiation 
states it makes the development of a unified isolation strategy difficult.  
As a general view, assuming that the liver stem cells are individual entities carrying 
specific markers is rather an outdated fact. Perhaps, our thinking on how liver stem cells had 
to work is hitherto mistaken and probably the parameters used to define them as well. For 
instance, it is becoming clear that the quiescent state is far from being a protected state as 
used to be thought (36-38). Liver repair is also achieved by expansion of many cells, with 
plasticity of the stem cells and mature cells and dedifferentiation emerging as common themes 
(Figure 1A). For instance, by switching on cellular and metabolic plasticity upon response to 
injury, the rates and types of cell production have to be rapidly adjusted to meet the tissue’s 
cellular and metabolic requirements (38, 39). Could it be that the markers cited earlier are 
involved in these matters? In the future, it would be rewarding to examine whether such 
critical events may be correlated to particular presence of aforementioned markers. In this 
concise review, we focus on Lgr5 and EpCAM, as markers that could potentially offer 
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EpCAM as a marker of liver cells during homeostasis 
Epithelial cell adhesion molecule (or EpCAM) is a transmembrane glycoprotein that is 
frequently expressed in cancer (40). EpCAM is composed of a large N-terminal extracellular 
domain (called EpEX) linked to a short C-terminus fragment (named EpICD) by a single-
transmembrane domain (see Figure 2A). Recently, EpCAM was recognized as a marker for 
pluripotent stem cells in human and mice and for tissue stem cells (reviewed in ref (40)). 
EpCAM can interact with proteins like E-cadherin or claudins to modulate cell-cell contact, 
regulate the activity of signaling pathways or sequester molecules or receptors to prevent their 
biological effects (40) (see Figure 2A). EpCAM is a potent player in the maintenance of the 
polarized tissue and has been described to modulate the organization of the actin cytoskeleton 
(41), and actomyosin contractility (42). While, only its proliferative effect has formally been 
demonstrated (43), it is tempting to propose that EpCAM regulates the actomyosin network 
for functional purposes.  
 
Remarkably, EpCAM expression is not restricted to epithelial precursors but is also 
present in undifferentiated stem cells that are not yet assigned to a specific cell fate. During 
morphogenesis of pancreatic islets, EpCAM has been described as a morphoregulatory 
molecule (44) whereby EpCAM is highly expressed in fetal endocrine pancreas while the 
adult endocrine tissue exhibits low levels of expression. This developmentally regulated 
EpCAM expression has also been illustrated in other organs, such as kidney, lung, skin and 
thymus (reviewed in (40)). During liver development and homeostasis, EpCAM also 
demonstrates a dynamic expression, since it can be detected in immature cells, which 
gradually lose EpCAM along with their maturation into hepatocytes (16, 45, 46). So far, 
EpCAM is one of the most representative and successful markers used in isolating liver stem 
cells (Figure 1B). Notably, long-term culture of genome-stable EpCAM+ bipotent stem cells 
from adult human liver has been developed (47) (Figure 2B). 
 
 
Still many questions regarding the role of EpCAM in liver regeneration remain 
unanswered.  While, in vitro these cells show bi-potential competency, in vivo the reason of 
re-expression of EpCAM remains speculative (see Figure 2C). Data by Yoon et al. clearly 
indicate the existence of a hierarchically structured regeneration of the liver based on 
differentiation processes that require the re-expression of EpCAM (48). Recently, a possible 
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perspective on the role of EpCAM in the maturation of human hepatocyte buds has been 
elegantly shown. Briefly, the authors demonstrated that hepatocyte buds derived from 
progenitor cells (i.e. GS+/EpCAM+ cells), repopulate regions of extinct parenchyma in human 
cirrhosis by following a maturation process that involves a dynamic expression of EpCAM 
and GS (glutamine synthetase) (49) allowing us to think that EpCAM might be required for 
stem cell maturation. Furthermore, the associated microvasculature develops in concert with 
the maturation of buds, resulting in a loss of CD34 expression in the bud center with the 
appearance of developed well-defined sinusoids, while the periphery sustains a CD34-
positivity matching the dynamic of EpCAM expression (49). This potentially exhibits 
EpCAM as a molecular platform permitting endothelial cells (CD34+) recruitment to ensure 
correct liver cell differentiation. A similar scenario has been speculated for explaining the 
hematopoietic cells migration from the fetal liver to the adult bone marrow [see Figure 2C and 
ref (40)]. In response to injury, the plasticity of the hepatobiliary system has been recently 
unveiled (24). Interestingly, in this study EpCAM-positive cells density was matching to the 
distance traveled by the emerging biliary branches. Consequently, one could consider that 
EpCAM has a role in this structural flexibility or might play a role in the directionality of the 
biliary branches.  
Several reports have demonstrated that immediately after the injury, drastic changes in 
metabolism occur in the liver before the repair machineries are launched (see reviews (50-52) 
and references herein). Disturbance of the metabolic zonation upon injury lead to the 
hypothesis of whether sensing of this metabolic insufficiency may in fact be the initiator 
trigger for the regenerative response. It is then tempting to speculate that de novo EpCAM 
expression on adult hepatocytes in the lobular parenchyma in response to injury could be an 
adaptive response to compensate for the hepatic insufficiency by creating a different 
metabolic zonation (see Figure 2C). In this viewpoint, cellular plasticity of EpCAM, at 
cellular or tissue scales, is important because in one site (aka stem/progenitors) EpCAM 
might be dedicated for proliferation and in another site (aka hepatocytes) it can be required for 
response to hepatic insufficiency.  
 
Overall, recent studies highlight the importance of the epithelial diversity that surrounds the 
bile ducts, which probably could partially explain the extraordinary plasticity of the biliary 
tree. Intriguingly enough, by (re)-expressing EpCAM at cellular or tissue scales, or by 
exposing a different integrity of the full-length of EpCAM molecule, the liver cells are 
champions of cellular plasticity. Whether EpCAM has a role in liver tissue plasticity remains 
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an open question. 
 
Lgr5 as marker of liver cells following damage 
LGR5 is a G-protein-coupled receptor with a 7-transmembrane domain. Together with 
its paralogue LGR4, is crucial for maintaining proliferating progenitors and stem cells in the 
intestine (53). Biochemical analyses have identified the LGRs as receptors for R-spondins 
(RSPOs) (54). Following association with RSPO, LGR4/5/6 strongly promote the activity of 
Wnt-Frizzled mediated signaling (Figure 3A). In fact, RSPO-LGR binding results in removal 
of the E3 ubiquitin ligase RNF43, thus preventing the degradation of Frizzled which results in 
a more robust and prolonged Wnt signal emanating from a “stabilized” Wnt/ frizzled complex 
[reviewed in (54)]. Lineage tracing studies have confirmed that Lgr5+ cells are fast-dividing, 
long-lived adult stem cells in the hair follicles, the antro-pyloric stomach, and the gut 
[reviewed in (54)]. Also, the mammary epithelium, the developing kidney, the ovarian 
epithelium or supporting cells in the inner ear possess LGR5 positive cells [reviewed in (54)].  
In the liver, Wnt signaling is active in perivenous hepatocytes (55) and has been shown to 
induce the metabolic zonation of the liver lobule (56). Upon damage, either by hepatectomy 
(57), oval cell response (58) or central vein damage (22), Wnt signaling is highly activated 
[the role of Wnt and its effector beta-catenin is elegantly reviewed in (55) and is not the focus 
of this review]. While classical canonical Wnt target genes, such as Axin 2, are detected in 
homeostasis in centrilobular hepatocytes, reporter mice have failed to show expression of 
Lgr5 under normal physiological conditions (22), although RNA analysis indicates a basal 
expression of Lgr5 in this area (59). However, following liver damage, Lgr5, similarly to 
Foxl1 (19), marks a population of cells that proliferates and, as shown by lineage tracing, 
upon CCl4, DDC or MCDE damage, differentiate into hepatocytes and/or ductal cells (22). In 
vitro (Figure 3B), these damage-induced Lgr5+ cells exhibit stem cell potential; they can be 
expanded from single cells (clonogenic) into self-sustaining liver organoids, while at the same 
time are able to differentiate towards cholangiocytes and hepatocytes (bi-potentiality) in vitro 
and in vivo, after transplantation in FAH-/- mouse model (22). Unfortunately, Lgr5+ cells have 
not been transplanted in other liver disease models, such as following partial hepatectomy or 
injury from liver toxins. These models have proven very useful for the analysis of bi-
potentiality and stem cell behavior of neonatal and adult EpCAM+ cells derived from human 
donors	  (16, 17). Future studies are expected to answer this question. 
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Still many questions regarding the role of Lgr5 in liver regeneration remain unresolved. While 
in vitro, these cells show bi-potential competency, their behavior in vivo, is still unknown 
(Figure 3C). In fact, a drawback of the lineage tracing experiments using Lgr5Cre driver is 
that these experiments were not performed at the clonal level (as discussed above). Therefore, 
whether in vivo these Lgr5+ cells that appear after damage are bi-potential or indeed there are 
2 types of Lgr5 progenitors for the hepatocyte and ductal lineages (Figure 3C), remains 
unresolved. Also, because this marker only appears after damage, the cell-of origin from 
which these Lgr5+ cells arise in vivo is still unknown. Of note, in vitro, mouse ductal MIC1-
1C3+ cells (60) or human EpCAM+ liver cells generate liver organoids that express LGR5 
(47). Whether in vivo, EpCAM+ cells are the cells of origin of Lgr5–damage induced cells is 
unknown. 
 
Because of the essential role of Lgr5 in enhancing Wnt signaling, it is tempting to hypothesize 
that LGR5 could be sensing higher levels of Wnt upon damage, which in turn could be 
inducing an active proliferative response on those specific cells to repair the tissue and 
reinstate homeostasis. It is worth mentioning that the dynamics of Lgr5 expression following 
injury indicate that LGR5 should be expressed early after the onset of damage and should be 
switched off again once the tissue is regenerated (22). Thus, it is plausible to speculate that 
Lgr5 could be acting as a switch between on and off states that instructs the cells whether to 
proliferate or not depending on the levels of Wnt in the environment.  If that is the case, then, 
Lgr5 would be marking cells that exhibit high plasticity and can move back-and forth between 
different stem and differentiation states. If so, it is feasible to hypothesize that perturbations in 
the system could break the fine line between proliferation and differentiation and result in 
disastrous consequences such as tissue hyper-proliferation (cancer) or degeneration 
(cirrhosis). With respect to that option, it has been recently shown that murine liver cancer 
cells have a similar expression pattern to Lgr5 liver progenitors induced after damage (61), 
suggesting that deregulation of a Wnt-driven regenerative response could be a factor 
contributing to liver cancer. Of note, hepatocellular carcinomas harbor mutations in beta-
catenin or other Wnt pathway components, which could be reflecting a mechanism of the 
tissue to activate proliferation by enhancing Wnt signaling.  
 
Overall, we are just beginning to understand the role of Lgr5 in stem cell maintenance and 
repair. In the liver, future studies will be required to identify the cells from which Lgr5+ 
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damaged cells arise or the role of Lgr5 during regeneration. Whether in the liver Lgr5 is 
implicated in the tissue plasticity remains still an open question. 
 
Conclusions  
It is well established now that high proliferative tissues such as the gut or the skin have 
evolved mechanisms to prevent tissue degeneration in the event of damage to their bona-fide 
stem cell compartments. Thus, ablation of the stem cell pool results in the activation of 
“reserve” populations or, also on the de-differentiation of mature cell types towards a more 
stem cell state (potential/plasticity), that allows the repair of the tissue and reinstates 
homeostasis [(2)]. Similarly, increasing evidence suggests that the activation of a “stem cell 
state” in a priori non-stem cell pools is not unique to the gut or the skin but it occurs across 
many tissues. Thus, stomach (62) and lung (8) differentiated cells have also demonstrated the 
acquisition of stem cell properties (stem cell potential) upon damage to the tissue, in what are 
examples of cellular plasticity. Here, we have discussed the evidences on stem cell plasticity 
on the liver. The remarkable regeneration capacity of the liver under many different types of 
liver injury makes it a champion of cellular plasticity. Liver differentiated cells, potential 
resident stem cells and even bone marrow stem cells can be de-differentiated, activated or 
recruited, respectively, to recover the damaged liver. This capacity of cells to acquire a stem 
cell state may highlight a more universal phenomenon. Whether this plasticity is relevant to 
disease states is still yet to be determined, but recent evidence suggests that, at least in the 
intestine, dedifferentiation of non-stem cells results in acquisition of a tumor-initiating stem 
cell competency (63). Thus, highlighting the concept of bidirectional conversion and cellular 
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Legend captures. 
Figure 1: Plasticity concept. A) Diverse routes lead to liver regeneration. While in a 
quiescent, homeostatic state (1.), tissue is maintained primarily by proliferation of the 
subpopulations of mature hepatic cells capable of cell division; upon damage (2.) various cell 
sources have been described to be involved in the process of hepatic repair. Each of them is 
illustrated in one quarter of the grey hexagon; at the outer limits, the various cell sources are 
represented at their initial state, while the center of the hexagon represents their ultimate goal: 
produce new hepatocytes (but also new duct cells or ducts), While each cell source has its 
color, their differentiated state is illustrated in green. Stromal cells are shaped as stars; bone 
marrow derived cells as round cells; particular hepatocytes from the central vein are 
highlighted in blue. Biliary cells (and HSPCs) and transit-amplifying cells are represented as 
small greener blue cells respectively. B) Diverse isolated cells are defined as LPCs (liver 
progenitor cells). Using flow cytometry-based cell separation methods in combination with 
cell surface markers or functions or genetic tracers, liver cells with stem cell potential have 
been isolated as viable cells. Black illustrates cell-surface and genetic markers used in healthy 
livers, while red indicates markers used upon damage. Asterisk indicates function. Arrows 
indicate that whatever the nature of the isolated cells is, they all converge to the definition of 
“LPCs” C) Validation strategies of stem cell potential. Isolated cells are subjected to in vitro 
culture to evaluate their bidirectional differentiation and clonogenic potentials and organoid 
formation, and in vivo to repopulate the liver upon transplantation. Lately, genetic stability 
studies have been introduced. Until today, only EpCAM and Lgr5 have completed 
successfully this list. 
 
Figure 2: EpCAM as a marker of liver cells during homeostasis. A) Dynamics of EpCAM 
expression at the cellular level. The pleiotropic functions of EpCAM can be allocated to the 
full-length protein, as well as to EpCAM-derived fragments generated upon intramembrane 
proteolysis (40). Some functions are illustrated. B) Ex vivo, sorted and cultured EpCAM+ cells 
are able to form organoids, with high degree of plasticity	  (22, 47). C) Functional plasticity of 
EpCAM at tissue scale is illustrated: EpCAM could be a player in metabolic model of liver 
regeneration or as molecular platform for cell recruitment. EpCAM expression on peribiliary 
hepatocytes (namely, canal of Hering-associated hepatocytes found at the hepatocyte-biliary 
interface) could allow an efficient hepatobiliary linkage to drain bile. 
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Figure 3: Lgr5 as marker of liver cells following damage. A) Dynamics of Lgr5 expression 
at cellular level. B) Ex vivo, sorted and cultured Lgr5+ cells are able to form organoids, with 
high degree of plasticity	  (22, 47). C) In vitro, Lgr5 cells derive from BEC (47, 60). Because 
medium to grow hepatocytes in culture has not been established yet, the origin of Lgr5+ cells 
from hepatocytes cannot be addressed. In vitro, Lgr5 cells are bi-potential, generating the 2 
epithelial liver lineages, hepatocytes and BECs (22, 47). The cell of origin of Lgr5+ cells in 
vivo is still unknown. In vivo, Lgr5 cells trace into hepatocytes and BECs (22). Whether in 
vivo these Lgr5+ cells can generate both lineages or there are Lgr5 committed progenitors to 
each lineage is still unknown.  
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